News - Financial

Filter

Current filters:

Financial

Popular Filters

63 to 87 of 1451 results

Merck Serono’s Erbitux to be funded by CDF in England for mCRC

28-02-2014

The UK’s Cancer Drugs Fund (CDF) says that Erbitux (cetuximab) can be used in the first line setting…

ErbituxFinancialHealthcareMerck KGaAMerck SeronoNorthern EuropeOncologyPharmaceuticalUK

Bayer results boosted by strong pharma performance

Bayer results boosted by strong pharma performance

28-02-2014

Germany’s Bayer this morning posted financial results for 2013, showing that group sales for the year…

BayerFinancialPharmaceutical

Valeant Pharma returns to profit, boosted by B&L acquisition

27-02-2014

Canadian drugmaker Valeant Pharmaceuticals International has announces fourth quarter financial results…

Bausch & LombFinancialGenericsValeant Pharmaceuticals

Mylan 4th-qtr 2013 adjusted diluted EPS increases 20%, beating expectations

27-02-2014

US generics major Mylan reported financial results for the fourth-quarter and full year 2013, showing…

FinancialGenericsMylan Laboratories

Record-breaking recoveries from US DoJ/HHS joint efforts to combat health care fraud

27-02-2014

US Attorney General Eric Holder and Health and Human Services Secretary Kathleen Sebelius have released…

FinancialHealthcareLegalNorth AmericaPharmaceuticalUSA

Australian patients benefit from PBS changes; cancer research

27-02-2014

New medicines for glaucoma, diabetes and advanced soft tissue sarcoma have been approved for listing…

Asia-PacificAustraliaDiabetesFinancialHealthcareKombiglyzeOncologyPharmaceuticalResearchTrajentaVotrient

Merck returns rights to ridaforolimus to Ariad, whose 4th-qtr net loss widens

Merck returns rights to ridaforolimus to Ariad, whose 4th-qtr net loss widens

26-02-2014

US pharma giant Merck & Co has told partner Ariad Pharmaceutical that it is terminating its license agreement…

Ariad PharmaceuticalsFinancialLicensingMerck & CoOncologyPharmaceuticalridaforolimus

China set to overtake USA bioscience market

26-02-2014

Bioscience research in China is set to overtake the USA within the next five to ten years, data from…

Asia-PacificBiotechnologyChinaFinancialJapanResearchUSA

Core products boost UCB 2013 sales, but profits disappoint

26-02-2014

Belgium’s largest drugmaker UCB this morning reported financial results for 2013, with gross profit…

FinancialPharmaceuticalUCB

Vivus earnings beat expectations

25-02-2014

USA-based Vivus has reported fourth-quarter and full-year 2013 financial results that beat analysts’…

FinancialPharmaceuticalVivus

Endo agrees $193 million settlement with US Justice Dept over Lidoderm

23-02-2014

US drugmaker Endo Health Solutions and its subsidiary Endo Pharmaceuticals have agreed to pay $192.7…

Endo Health SolutionsFinancialLegalLidodermMarkets & MarketingNeurologicalPharmaceutical

Setting the record straight: Australia’s PBS expenditure is in decline

21-02-2014

Comments made this week by Australia’s federal Health Minister, Peter Dutton MP, about expenditure…

Asia-PacificAustraliaFinancialGenericsHealthcarePharmaceutical

Actavis net revenue rise 59% beats forecasts; non-GAAP EPS rises 99%

Actavis net revenue rise 59% beats forecasts; non-GAAP EPS rises 99%

20-02-2014

Acquisitive Ireland-headquartered generics major Actavis says that net revenue leapt 59% to $2.779 billion…

ActavisFinancialGenerics

Vitae Pharma earns $14 million milestone from Boehringer Ingelheim in Alzheimer's collaboration

Vitae Pharma earns $14 million milestone from Boehringer Ingelheim in Alzheimer's collaboration

20-02-2014

US clinical-stage biotech firm Vitae Pharmaceuticals says it has earned a $14 million milestone payment…

BiotechnologyBoehringer IngelheimFinancialNeurologicalResearchVitae Pharmaceuticals

Funding restrictions for rituximab and eltrombopag widened in New Zealand

Funding restrictions for rituximab and eltrombopag widened in New Zealand

20-02-2014

New Zealand’s Pharmaceutical Management Agency PHARMAC has announced the approval of proposals to widen…

Asia-PacificeltrombopagFinancialGlaxoSmithKlineHealthcareImmunologicalsNew ZealandPharmaceuticalrituximabRoche

Fitch affirms Actavis at “BBB-” on Forest Labs acquisition; outlook Stable

20-02-2014

Fitch Ratings has affirmed the ratings of generic drugs major Actavis and subsidiaries at “BBB-”…

ActavisFinancialForest LaboratoriesMergers & AcquisitionsPharmaceutical

Lundbeck raises $1.2 million by increasing share capital

Lundbeck raises $1.2 million by increasing share capital

19-02-2014

Danish CNS drug specialist Lundbeck will raise 6,753,283 Danish kroner ($1,242,714) by increasing its…

DenmarkFinancialLundbeckPharmaceutical

Mologen raises cash to fund Phase III trial of colorectal cancer drug

19-02-2014

German drug development company Mologen has raised 15.7 million euros ($21.6 million) in order to fund…

FinancialGermanyOncologyPharmaceuticalResearch

Report: IPOs and government support can boost the Australian life sciences industry

Report: IPOs and government support can boost the Australian life sciences industry

18-02-2014

Despite a relatively flat December quarter for the PricewaterhouseCoopers Life Sciences Index, it was…

AustraliaBiotechnologyCSL LimitedFinancialMarkets & MarketingPharmaceutical

New NPS MedicineWise annual evaluation report indicates Australian PBS savings

New NPS MedicineWise annual evaluation report indicates Australian PBS savings

18-02-2014

The 16th NPS MedicineWise Annual Evaluation Report provides a snapshot of the organization’s progress…

Asia-PacificAustraliaFinancialHealthcarePharmaceutical

Servier Canada collaborates in two research projects

Servier Canada collaborates in two research projects

17-02-2014

Two major projects in clinical research conducted by Canada’s Montreal Heart Institute (MHI) and the…

CanadaCardio-vascularFinancialNorth AmericaPharmaceuticalResearchServier

Co-payments and co-insurance fees for drugs rise 34% under USA’s Affordable Care Act

Co-payments and co-insurance fees for drugs rise 34% under USA’s Affordable Care Act

14-02-2014

An examination of new health plans from 46 states in the USA revealed that co-payments and co-insurance…

FinancialHealthcareNorth AmericaPharmaceuticalUSA

Another milestone for GenVec in hearing and balance collaboration

13-02-2014

US biotech firm GenVec says it has achieved the third milestone in its collaboration with Swiss drug…

BiotechnologyCGF166FinancialGenVecLicensingNeurologicalNovartis

Shire posts top year-end results and expects earnings to rise again in 2014

Shire posts top year-end results and expects earnings to rise again in 2014

13-02-2014

Ireland-headquartered drugmaker Shire has recorded a rise in sales and earnings to deliver strong full-year…

DermagraftFinancialFirazyrIntunivLialdaMezavantNorthern EuropePharmaceuticalShireViroPharmaVprivVyvanse

63 to 87 of 1451 results

Back to top